Hedgehog signaling pathway gene variant influences bronchopulmonary dysplasia in extremely low birth weight infants.


Journal

World journal of pediatrics : WJP
ISSN: 1867-0687
Titre abrégé: World J Pediatr
Pays: Switzerland
ID NLM: 101278599

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 14 12 2020
accepted: 22 03 2021
pubmed: 17 4 2021
medline: 15 12 2021
entrez: 16 4 2021
Statut: ppublish

Résumé

Genome wide association study identified hedgehog interacting protein gene (HHIP) variants with chronic obstructive pulmonary disease and asthma. Loss of HHIP, a key regulator of the hedgehog signaling pathway, leads to impaired lung morphogenesis and lethality in animal models, through unimpeded sonic hedgehog expression blocking mesenchymal-expressed fibroblast growth factor 10 (FGF10). Since bronchopulmonary dysplasia (BPD) is also associated with altered lung development and worsens with stimuli including mechanical ventilation, reactive oxygen species, and inflammation, HHIP and FGF10 may be candidate genes. This was an observational, cohort study including extremely low birth weight infants that who developed BPD and those who did not. DNA was isolated from buccal swabs and subjected to allelic discrimination, using specific HHIP and FGF10 probes. Protein levels were measured in tracheal aspirates. Student's t test, Chi-square, Z test and logistic regression were used. Demographic characteristics did not differ except that birth weight (715 ± 153 vs. 835 ± 132 g) and gestational age (25 vs. 26 weeks) were less in babies with BPD. HHIP variant rs13147758 (GG genotype) was found to be independently protective for BPD (odds ratio 0.35, 95% confidence interval 0.15-0.82, P = - 0.02). Early airway HHIP protein levels were increased in infants with BPD compared to those without [median (interquartile range) 130.6 (55.6-297.0) and 41.2 (22.1-145.6) pg/mL, respectively; P = 0.05]. The FGF10 single nucleotide polymorphisms were not associated with BPD. HHIP, as a regulator of lung bud formation, affects BPD susceptibility, and may be valuable in understanding the specific mechanisms for this disease as well as for identifying therapeutic targets in the era of personalized medicine.

Sections du résumé

BACKGROUND BACKGROUND
Genome wide association study identified hedgehog interacting protein gene (HHIP) variants with chronic obstructive pulmonary disease and asthma. Loss of HHIP, a key regulator of the hedgehog signaling pathway, leads to impaired lung morphogenesis and lethality in animal models, through unimpeded sonic hedgehog expression blocking mesenchymal-expressed fibroblast growth factor 10 (FGF10). Since bronchopulmonary dysplasia (BPD) is also associated with altered lung development and worsens with stimuli including mechanical ventilation, reactive oxygen species, and inflammation, HHIP and FGF10 may be candidate genes.
METHODS METHODS
This was an observational, cohort study including extremely low birth weight infants that who developed BPD and those who did not. DNA was isolated from buccal swabs and subjected to allelic discrimination, using specific HHIP and FGF10 probes. Protein levels were measured in tracheal aspirates. Student's t test, Chi-square, Z test and logistic regression were used.
RESULTS RESULTS
Demographic characteristics did not differ except that birth weight (715 ± 153 vs. 835 ± 132 g) and gestational age (25 vs. 26 weeks) were less in babies with BPD. HHIP variant rs13147758 (GG genotype) was found to be independently protective for BPD (odds ratio 0.35, 95% confidence interval 0.15-0.82, P = - 0.02). Early airway HHIP protein levels were increased in infants with BPD compared to those without [median (interquartile range) 130.6 (55.6-297.0) and 41.2 (22.1-145.6) pg/mL, respectively; P = 0.05]. The FGF10 single nucleotide polymorphisms were not associated with BPD.
CONCLUSION CONCLUSIONS
HHIP, as a regulator of lung bud formation, affects BPD susceptibility, and may be valuable in understanding the specific mechanisms for this disease as well as for identifying therapeutic targets in the era of personalized medicine.

Identifiants

pubmed: 33860472
doi: 10.1007/s12519-021-00427-y
pii: 10.1007/s12519-021-00427-y
doi:

Substances chimiques

Hedgehog Proteins 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

298-304

Références

Bhandari V, Gruen JR. The genetics of bronchopulmonary dysplasia. Semin Perinatol. 2006;30:185–91.
doi: 10.1053/j.semperi.2006.05.005
Maduekwe E, DeCristofaro JD. Adjunctive therapies in bronchopulmonary dysplasia. NeoReviews. 2017;18:e173–9.
doi: 10.1542/neo.18-3-e173
Whitsett JA, Wert SE, Trapnell BC. Genetic disorders influencing lung formation and function at birth. Hum Mol Genet. 2004;13(Suppl 2):R207–15.
doi: 10.1093/hmg/ddh252
Lavoie PM, Pham C, Jang KL. Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health. Pediatrics. 2008;122:479–85.
doi: 10.1542/peds.2007-2313
Berndt A, Leme AS, Shapiro SD. Emerging genetics of COPD. EMBO Mol Med. 2012;4:1144–55.
doi: 10.1002/emmm.201100627
Lal CV, Ambalavanan N. Genetic predisposition to bronchopulmonary dysplasia. Semin Perinatol. 2015;39:584–91.
doi: 10.1053/j.semperi.2015.09.004
Cardoso WV, Lü J. Regulation of early lung morphogenesis: questions, facts and controversies. Development. 2006;133:1611–24.
doi: 10.1242/dev.02310
Jobe AH, Whitsett JA, Abman SH. Fetal & neonatal lung development. Cambridge: Cambridge University Press; 2016.
doi: 10.1017/CBO9781139680349
Chuang PT, Kawcak T, McMahon AP. Feedback control of mammalian Hedgehog signaling by the Hedgehog-binding protein, Hip1, modulates Fgf signaling during branching morphogenesis of the lung. Genes Dev. 2003;17:342–7.
doi: 10.1101/gad.1026303
Zhou X, Baron RM, Hardin M, Cho MH, Zielinski J, Hawrylkiewicz I, et al. Identification of a chronic obstructive pulmonary disease genetic determinant that regulates HHIP. Hum Mol Genet. 2012;21:1325–35.
doi: 10.1093/hmg/ddr569
Zhou X, Qiu W, Sathirapongsasuti JF, Cho MH, Mancini JD, Lao T, et al. Gene expression analysis uncovers novel hedgehog interacting protein (HHIP) effects in human bronchial epithelial cells. Genomics. 2013;101:263–72.
doi: 10.1016/j.ygeno.2013.02.010
Olsen CL, Hsu PP, Glienke J, Rubanyi GM, Brooks AR. Hedgehog-interacting protein is highly expressed in endothelial cells but down-regulated during angiogenesis and in several human tumors. BMC Cancer. 2004;4:43.
doi: 10.1186/1471-2407-4-43
Young RP, Hopkins RJ, Whittington CF, Hay BA, Epton MJ, Gamble GD. Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPD. PLoS One. 2011;6:e16476.
doi: 10.1371/journal.pone.0016476
Fagerberg L, Hallström BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2014;13:397–406.
doi: 10.1074/mcp.M113.035600
Szabo L, Morey R, Palpant NJ, Wang PL, Afari N, Jiang C, et al. Statistically based splicing detection reveals neural enrichment and tissue-specific induction of circular RNA during human fetal development. Genome Biol. 2015;16:126.
doi: 10.1186/s13059-015-0690-5
Li X, Howard TD, Moore WC, Ampleford EJ, Li H, Busse WW, et al. Importance of hedgehog interacting protein and other lung function genes in asthma. J Allergy Clin Immunol. 2011;127:1457–65.
doi: 10.1016/j.jaci.2011.01.056
Young RP, Whittington CF, Hopkins RJ, Hay BA, Epton MJ, Black PN, et al. Chromosome 4q31 locus in COPD is also associated with lung cancer. Eur Respir J. 2010;36:1375–82.
doi: 10.1183/09031936.00033310
Budulac SE, Postma DS, Hiemstra PS, Lapperre TS, Vonk JM, Timens W, et al. Hedgehog-interacting protein (HHIP) polymorphisms and chronic obstructive pulmonary disease (COPD). Eur Respir J. 2011;38:314.
Wilk JB, Chen TH, Gottlieb DJ, Walter RE, Nagle MW, Brandler BJ, et al. A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet. 2009;5:e1000429.
doi: 10.1371/journal.pgen.1000429
Wang B, Zhou HX, Yang J, Xiao J, Liang BM, Li DX, et al. Association of HHIP polymorphisms with COPD and COPD-related phenotypes in a Chinese Han population. Gene. 2013;531:101–5.
doi: 10.1016/j.gene.2013.08.069
Xu GH, Gao XY, Zhang SN, Wang Y, Ding MJ, Liu WY, et al. Comparison of the role of HHIP SNPs in susceptibility to chronic obstructive pulmonary disease between Chinese Han and Mongolian populations. Gene. 2017;637:50–6.
doi: 10.1016/j.gene.2017.09.035
Wang P, Liu Y, Ren JT. Relationship between gene polymorphism in FGF10 and susceptibility to 220 patients with COPD. Eur Respir J. 2014;44:2955.
Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics. 2005;116:1353–60.
doi: 10.1542/peds.2005-0249
Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M, et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants. An evidence-based approach. Am J Respir Crit Care Med. 2019;200:751–9.
doi: 10.1164/rccm.201812-2348OC
Ortega-Martínez A, Pérez-Rubio G, Ambrocio-Ortiz E, Nava-Quiroz KJ, Hernández-Zenteno RJ, Abarca-Rojano E, et al. The SNP rs13147758 in the HHIP gene is associated with COPD susceptibility, serum, and sputum protein levels in smokers. Front Genet. 2020;11:882.
doi: 10.3389/fgene.2020.00882
Lao T, Jiang Z, Yun J, Qiu W, Guo F, Huang C, et al. Hhip haploinsufficiency sensitizes mice to age-related emphysema. Proc Natl Acad Sci U S A. 2016;113:E4681–7.
doi: 10.1073/pnas.1602342113
Smith BM, Traboulsi H, Austin JHM, Manichaikul A, Hoffman EA, Bleecker ER, et al. Human airway branch variation and chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A. 2018;115:E974–81.
doi: 10.1073/pnas.1715564115
Benjamin JT, Smith RJ, Halloran BA, Day TJ, Kelly DR, Prince LS. FGF-10 is decreased in bronchopulmonary dysplasia and suppressed by Toll-like receptor activation. Am J Physiol Lung Cell Mol Physiol. 2007;292:L550–8.
doi: 10.1152/ajplung.00329.2006
Danopoulos S, Thornton ME, Grubbs BH, Frey MR, Warburton D, Bellusci S, et al. Discordant roles for FGF ligands in lung branching morphogenesis between human and mouse. J Pathol. 2019;247:254–65.
pubmed: 30357827
Rezvani M, Wilde J, Vitt P, Mailaparambil B, Grychtol R, Krueger M, et al. Association of a FGFR-4 gene polymorphism with bronchopulmonary dysplasia and neonatal respiratory distress. Dis Markers. 2013;35:633–40.
doi: 10.1155/2013/932356

Auteurs

Shaili Amatya (S)

Newborn Medicine Division, The Regional Neonatal Intensive Care Unit, Maria Fareri Children's Hospital At Westchester Medical Center, Valhalla, NY, USA.
Department of Pediatrics, New York Medical College, Valhalla, NY, USA.
Department of Pediatrics, Penn State Children's Hospital, Hershey, PA, USA.

Sharina Rajbhandari (S)

Newborn Medicine Division, The Regional Neonatal Intensive Care Unit, Maria Fareri Children's Hospital At Westchester Medical Center, Valhalla, NY, USA.
Department of Pediatrics, New York Medical College, Valhalla, NY, USA.
Novant Health Presbyterian Medical Center, Charlotte, NC, USA.

Sandeep Pradhan (S)

Department of Public Health, Penn State University, Hershey, PA, USA.

Van Trinh (V)

Newborn Medicine Division, The Regional Neonatal Intensive Care Unit, Maria Fareri Children's Hospital At Westchester Medical Center, Valhalla, NY, USA.
Department of Pediatrics, New York Medical College, Valhalla, NY, USA.

Umesh Paudel (U)

Department of Pediatrics, Harlem Hospital-Columbia University Irving Medical Center, New York, NY, USA.

Lance A Parton (LA)

Newborn Medicine Division, The Regional Neonatal Intensive Care Unit, Maria Fareri Children's Hospital At Westchester Medical Center, Valhalla, NY, USA. lparton7@gmail.com.
Department of Pediatrics, New York Medical College, Valhalla, NY, USA. lparton7@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH